The Indian pharmaceutical industry is estimated to be worth USD 21.5 billion as of 2009-10 and is expected to grow at a CAGR of 16-18 percent during 2009-2010 to 2014-15 to reach USD 43-46 billion.




There is a huge opportunity for Indian generics players with many blockbuster drugs going off-patent in the next five years. The sub-sectors such as biopharmaceuticals and Contract Research and Manufacturing Services (CRAMS) are expected to become the new frontiers of growth.  India is increasingly being looked at as a preferred destination for clinical trials and other services.


With such high growth predicted for the industry, the challenges the industry will have to overcome will be at a global level.

How can we help


KPMG’s industry-focused professionals understand the pharmaceutical sector and can assist you in recognizing and capitalizing on the opportunities that exist. Our professionals offer a powerful blend of industry insight and proven credentials to help you and your organization successfully achieve its mission and objectives. Our audit, tax and advisory practices offer a bouquet of solutions to the pharmaceutical industry. A few of these solutions are listed below:


    Tax Advisory and Compliance Services

    • Corporate Tax and Regulatory Services
    • Transfer Pricing Services
    • Indirect Tax Services including Tax Outsourcing
    • International Executive Services
    • M&A Tax Services
    • Others



    • M&A Advisory
    • Financing Advisory
    • Valuation Services
    • Due Diligence Services
    • Risk Management Services
    • Internal Audit Services
    • Fraud & Misconduct Services
    • Forensic Technology Services
    • Business Plan Formulation and Implementation
    • Market Entry and Expansion Strategy
    • Others



To be decided

Utkarsh Palnitkar
Head of Life Sciences


KPMG in India is the official knowledge partner for BioAsia scheduled for February 2016. The thirteenth edition of BioAsia will be organized with the theme of leveraging India to succeed globally and shall focus on connecting the dots to build stakeholder consensus and draw a distinct road-map to propel the sector growth.Please click here to know more...